gipper: I don't think this was a good career move for Jason. To say Lympro will only bring in one million in 2015 and 3.5 million in 2016 is simply outrageous. I don't know how to take him seriously anymore.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links